Connor, J. P., Cristea, M. C., Lewis, N. L., Lewis, L. D., Komarnitsky, P. B., Mattiacci, M. R., . . . Stupp, R. (2013). A phase 1b study of humanized KS-interleukin-2 (huKS-IL2) immunocytokine with cyclophosphamide in patients with EpCAM-positive advanced solid tumors. BioMed Central.
Chicago Style CitationConnor, Joseph P., et al. A Phase 1b Study of Humanized KS-interleukin-2 (huKS-IL2) Immunocytokine With Cyclophosphamide in Patients With EpCAM-positive Advanced Solid Tumors. BioMed Central, 2013.
MLA CitationConnor, Joseph P., et al. A Phase 1b Study of Humanized KS-interleukin-2 (huKS-IL2) Immunocytokine With Cyclophosphamide in Patients With EpCAM-positive Advanced Solid Tumors. BioMed Central, 2013.
Warning: These citations may not always be 100% accurate.